Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
6
67%
Ph phase_2
1
11%
Ph phase_4
1
11%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(4)
Terminated(2)
Other(3)

Detailed Status

Completed4
unknown3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (12.5%)
Phase 41 (12.5%)
N/A6 (75.0%)

Trials by Status

unknown333%
completed444%
withdrawn222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9